Generics 12

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Omeprazole manufacturers

12 products found

Filters

Filters

Filters , active

Country of origin : Greece

Clear all

12 products found

omeprazole

Capsules 20 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Registered in
Greece
Manufacturer #17290
A pharmaceutical manufacturer based in the EU that is active in Europe, Africa, and Asia for 100+ years. Key production lines are pharmaceuticals, food supplements, OTC, and cosmetics. The main therapeutic areas include dermatology, respiratory system, and antibiotic.

Manufacturer usually replies in 4 days

omeprazole

Capsules, enteric coated 20 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Available for
Licensing with supply, Distribution only
Manufacturer #17293
It was founded in the 1970s. It has developed rapidly since it introduced innovative promotional methods to the pharmaceutical market, and as a result, it established a prominent position in the field of Dermatology. its export activities are currently being developed in over 45 countries across five continents. The company has cooperated with the most reliable companies at a worldwide level, and by expanding its product portfolio, it now offers unique and effective solutions to several dermatological problems.

Manufacturer usually replies in 4 days

omeprazole

Tablets 20 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #17291
A Scientific and techno-commercial consulting company that deals with innovative and practical based solutions. Their sole aim is to cover and prioritize the healthcare needs of the public to benefit the people.

Manufacturer usually replies in 8 days

omeprazole

Powder and solvent for solution for injection 40 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Germany
Available for
Licensing with supply, Distribution only
Manufacturer #16255
The company is a 100% Greek pharmaceutical company whose major activities are the creation and trading of branded generic pharmaceutical products while maintaining a high level of patient respect and devotion. It is the holder of more than 70 marketing authorizations for pharmaceutical products and the launcher of more than 46 of them.

Manufacturer usually replies in 8 days

omeprazole

Capsules, gastro resistant (GR) 20 mg, 40 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Estonia , Iraq , Latvia , Libya , Lithuania , Vietnam
Manufacturer #2346

Manufacturer usually replies in 9 days

omeprazole

Solution for injection/infusion 40 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Estonia , Iraq , Latvia , Libya , Lithuania , Vietnam
Manufacturer #2346

Manufacturer usually replies in 9 days

omeprazole

Vials, injection 40mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #623

Manufacturer usually replies in 9 days

omeprazole

Vials, injection 40 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Kosovo
Manufacturer #298

Manufacturer usually replies in 5 days

omeprazole

Capsules 20mg, 40mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Available for
Licensing with supply, Distribution only
Manufacturer #16255
The company is a 100% Greek pharmaceutical company whose major activities are the creation and trading of branded generic pharmaceutical products while maintaining a high level of patient respect and devotion. It is the holder of more than 70 marketing authorizations for pharmaceutical products and the launcher of more than 46 of them.

Manufacturer usually replies in 8 days

omeprazole

Capsules, gastro resistant (GR) 20 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Kosovo
Manufacturer #298

Manufacturer usually replies in 5 days

omeprazole

Capsules 20mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #16299
The company has a manufacturer’s license for medicinal products for human use authorized by the National Agency of Medicines. The highest quality products are manufactured and packaged in the production units with GMP International Standards and regularly checked by the National Agency of Medicines by the requirements of the European Medicines Agency (EMEA). The principal activity of the company is the production of pharmaceutical products, which are certified with patents, in various forms (tablets, capsules, syrups, oral solutions, powders for liquid compositions, gels, creams, and ointments) and various categories (antibiotics, antifungals, antivirals, anti-inflammatories, analgesics, antipyretics, anxiolytics, antidepressants, bronchodilators, antilipidemics, antitussives, cholinesterase inhibitors, antipsoriatics, antacids, anticholinergics, antidiarrheals, etc.).

Manufacturer usually replies in 15 days

omeprazole

Capsules 20 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Available for
Licensing with supply
Manufacturer #15932

A pharmaceutical manufacturer based in the EU that is active in 20+ countries for 20+ years. Key production lines are generic, medical device, OTC, nutraceuticals, and cosmetics. They are produced in GMP-compliant manufacture. Main therapeutic areas include allergology and pulmonology, cardiology, dermatology, and the central nervous system. The main dosage forms are liquid, solid, semi-solid, and sprays.

Manufacturer usually replies in 11 days

Omeprazole manufacturers

What is Omeprazole?

Omeprazole is a drug that belongs to a class of pharmaceuticals called proton pump inhibitors (PPIs). It is used to treat conditions caused by excess stomach acid, including gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome, a rare condition that causes the stomach to produce too much acid.

Omeprazole works by blocking the enzyme in the stomach wall that produces acid, which helps reduce the amount of acid produced. This can help to relieve symptoms such as heartburn, chest pain, and difficulty swallowing.

Omeprazole is available in several forms, including capsules, tablets, and powder for oral suspension. It is usually taken once a day before a meal, and the dose and duration of treatment can vary depending on the condition and the patient's needs.

Omeprazole is available by prescription and over-the-counter in many countries and is one of the most commonly prescribed medications for acid-related conditions. It is generally considered safe and effective when used as directed. Still, like all medications, it can have potential side effects and interactions with other drugs, so it's important to talk to a healthcare provider before taking Omeprazole.

Omeprazole forms and dosage

Omeprazole is available in several forms, including capsules, tablets, and powder for oral suspension. The dose and duration of treatment can vary depending on health conditions and the patient's needs.

For most conditions, the usual recommended dose of Omeprazole is 20 mg taken once daily, although higher doses may be used for certain conditions. The medication is usually taken before a meal, and it is important to swallow the capsule or tablet whole without crushing, breaking, or chewing it.

For patients with difficulty swallowing, omeprazole powder for oral suspension can be mixed with water and taken by mouth or a feeding tube. The dose and duration of treatment with omeprazole powder for oral suspension can vary depending on the patient's needs and the treated condition.

The duration of treatment can vary depending on the condition being treated and the patient's individual needs, and it's important to complete the full course of treatment even if symptoms improve.

Omeprazole patent information

The patent for Omeprazole has expired in many countries, including the United States, Canada, and most of Europe. The original patent for Omeprazole was filed by AstraZeneca, the company that developed and marketed the medication, in the early 1980s and was granted in 1986. The patent expired in the United States in 2001 and in Europe in 2002, allowing other companies to start producing and marketing generic versions of the medication.

However, AstraZeneca also holds additional patents related to Omeprazole formulations, methods of use, and other aspects of the medication, which can limit the ability of other companies to produce and market certain Omeprazole products. These patents can vary in expiration dates and geographic scope.

Omeprazole manufacturers and brand names

Omeprazole is manufactured by several pharmaceutical companies worldwide and is available under various brand names. Some of the most well-known brand names for Omeprazole include:

  • Prilosec (marketed by AstraZeneca in the United States)
  • Losec (marketed by AstraZeneca in Europe and other regions)
  • Zegerid (marketed by Santarus and Salix Pharmaceuticals in the United States)
  • Omez (marketed by Dr. Reddy's Laboratories in India)
  • Omebeta (marketed by Betapharm Arzneimittel GmbH in Germany)
  • Omepral (marketed by Pfizer in some countries).

These are just a few examples of the many brand names under which Omeprazole is sold. Generic versions of Omeprazole are also available under various names, depending on the manufacturer and the country.

There is a long list of available manufacturers and suppliers of Omeprazole. These include Actavis Labs, Apotex, Aurobindo Pharma, Breckenridge, Dr. Reddys, Glenmark Generics, Hetero Labs, Impax Labs, Lannett, Lupin, Mylan, Sandoz, Teva, Xiromed, Zydus, AstraZeneca, Dexcel Pharma, Sun Pharm, Spil, Covis, Perrigo, Ajanta Pharma, Aurolife Pharma, Guardian Drug, Par Pharm, Unicorn, Salix and Bayer.

Omeprazole wholesale price

In the United States, the wholesale price of a 30-day supply of 20 mg omeprazole capsules can range from around $10 to $80, depending on the manufacturer and the vendor. However, these prices can vary depending on the specific market conditions, and individual pharmacies may charge different prices.

In the United Kingdom, the NHS drug tariff price for a 28-day supply of 20mg omeprazole capsules is £4.92, while the price of a 28-day supply of 40mg omeprazole capsules is £5.04. 

The German Federal Joint Committee (G-BA) sets reimbursement prices for prescription drugs in Germany, which can serve as a reference for the wholesale prices of drugs. As of January 2023, the G-BA reimbursement price for a 30-day supply of 20mg omeprazole capsules is €2.58, while the price for a 30-day supply of 40mg omeprazole capsules is €2.90.

However, these prices may not reflect the actual cost to pharmacies or other healthcare providers, as they do not account for other factors, such as shipping, handling, and insurance costs.

Omeprazole versus Omeprazole Sodium

Omeprazole and Omeprazole Sodium are similar but not identical medicines. Omeprazole Sodium is a salt form of Omeprazole that is often used in injectable formulations. Because it is in a salt form, Omeprazole Sodium is more soluble in water than Omeprazole, making it easier to administer by injection.

Although Omeprazole and Omeprazole sodium have similar pharmacological effects, they may have different dosages and indications for use. Omeprazole is typically used to treat conditions such as gastroesophageal reflux disease (GERD), ulcers, and Zollinger-Ellison syndrome, while Omeprazole Sodium may be used in hospitals for the treatment of conditions such as bleeding ulcers or severe acid reflux.

It's important to note that Omeprazole and Omeprazole Sodium are not interchangeable without the guidance of a healthcare professional.

Connecting to Omeprazole manufacturers and suppliers

Pipelinepharma is a B2B platform that helps pharma buyers find reliable Omeprazole manufacturers worldwide. The platform provides access to a global network of verified suppliers, allows easy connection and negotiation, and offers competitive pricing. Buyers can also access regulatory information on suppliers to ensure they meet quality standards. Pipelinepharma simplifies product sourcing and helps buyers find the best deal partners.

There are 500+ Omeprazole products on the Pipelinepharma marketplace supplied by different manufacturers. The products can be found in the Generics category. Sign up on Pipelinepharma free of charge and search for all available Omeprazole options.